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Introduction {#sec1}
============

One of the first and most important steps in vertebrate development is the establishment of the three germ layers, ectoderm, mesoderm, and endoderm. In all vertebrates, the transforming growth factor β (TGF-β) superfamily member Nodal is essential for this process and is thought to act in a morphogen gradient. High prolonged Nodal signaling is required for the specification of endoderm, while lower levels are thought to promote mesoderm induction ([@bib22], [@bib65]). However, additional signaling pathways, for example Wnt, BMP, and Fgf, operate upstream and downstream of Nodal, and it is poorly understood how these pathways interact with Nodal to allocate cells to the endodermal versus the mesodermal lineages ([@bib24], [@bib48]). This question is of fundamental importance for understanding vertebrate development, but also for future application of directed differentiation of stem cells in regenerative medicine ([@bib53]).

Nodal ligands signal through a serine/threonine kinase receptor complex comprising two copies each of a type I receptor (Acvr1ba, also called Taram-a) and a type II receptor (Acvr2a/b), together with the co-receptor Tdgf1 (also called Oep) ([@bib47]). Binding of Nodal to its receptors leads to phosphorylation of the intracellular signal transducer Smad2, which subsequently binds Smad4. Smad2-Smad4 complexes then accumulate in the nucleus where, together with additional transcription factors, such as FoxH1 and Mixer, they induce a mesoderm- and endoderm-specific transcriptional program ([@bib63]).

In zebrafish, two Nodal ligands, Nodal-related 1 and 2 (Ndr1/2) specify mesoderm and endoderm at the blastula margin between sphere and shield stages (4--6 hr post fertilization \[hpf\]) ([@bib17], [@bib22], [@bib46]). Nodal signaling in the ventral and lateral margin is initiated by Ndr1/2 secreted by the yolk syncytial layer (YSL), which signals to the overlying blastoderm. Since *ndr1/2* are transcriptional targets of the Nodal pathway, signaling spreads away from the YSL to form a graded signaling domain within the first five cell tiers ([@bib15], [@bib58]). This occurs rapidly in about 1.3 hr between sphere stage (4 hpf) and 50% epiboly (5.3 hpf), and results in a spatial and temporal gradient of Nodal signaling, with cells closest to the YSL signaling for the longest duration. The size of the Nodal signaling domain is determined by the interplay between Ndr1/2, the Nodal antagonists Lefty1 and Lefty2 (Lft1 and Lft2, respectively) and the *miR-430* family of microRNAs ([@bib58]). The consequence of this temporal gradient is that cells directly adjacent to the YSL accumulate the highest levels of phosphorylated Smad2 (P-Smad2).

Interestingly, a Nodal signaling gradient is sufficient to organize a complete embryonic axis at the animal pole, when an opposing BMP gradient is introduced ([@bib64]). This illustrates that Nodal triggers a cascade of signaling pathways that orchestrates morphogenetic events. One of the first pathways activated within this cascade is Fgf signaling, since several Fgf ligands, including *fgf3* and *fgf8a*, are transcriptional targets of the Nodal pathway ([@bib34]). Fgf ligands are secreted glycoproteins that bind specific tyrosine kinase receptors (FgfR1a/1b/2) to activate multiple signaling branches, including the Stat1/3/5, Plcγ-Pkc, PI3K-Pkb, and the Ras-Raf-Mek1/2-Erk1/2 pathways ([@bib13], [@bib41]). Importantly, Fgf signaling is rapidly activated and highly dynamic as it is subject to negative feedback at multiple levels of the pathway. Negative regulators include enzymes such as the dual specificity phosphatase Dusp6 (also called Mkp3), which can dephosphorylate Erk1/2, and the E3 ubiquitin ligase CBL, which functions at the level of the receptor, as well as non-enzymatic antagonists such as Sef and Spry2/4, which inhibit signaling at multiple points in the pathway ([@bib16], [@bib29], [@bib55]). The importance of the signaling dynamics of the Fgf pathway in mesoderm and endoderm specification is largely unknown.

Within the zebrafish marginal domain, mesoderm is specified in up to ten cell tiers from the YSL, whereas endoderm is specified predominantly in the first two cell tiers ([@bib40], [@bib48]). Interestingly, only a subset of cells in the first two cell tiers give rise to endoderm, which results in endodermal progenitors being intermingled with mesodermal progenitors prior to gastrulation ([@bib12], [@bib26], [@bib60]). Although it is clear that Nodal signaling is required for both endoderm and mesoderm specification, it is currently not known what molecular mechanisms control the separation of these lineages. In prospective endoderm progenitors, Nodal induces the expression of the endoderm-specific transcription factor and master regulator, Sox32, which, in conjunction with the evolutionary-conserved transcription factors Foxa2, Gata5, and Sox17, initiate an endoderm-specific transcriptional program ([@bib1], [@bib12], [@bib26], [@bib40]). Mesoderm is marked and specified by transcription factors including the T-box transcription factors Ta (also called No-tail or Brachyury), Eomesa, Tbx16, and the homeobox transcription factor Noto (also called Floating head) ([@bib51], [@bib54], [@bib59]). We recently demonstrated that transcription of mesodermal markers beyond the Nodal signaling domain is induced by Fgf signaling, which is activated downstream of Nodal ([@bib58]). However, the activation of Fgf signaling by Nodal presents a paradox with respect to the formation of endoderm, since Fgf signaling is known to inhibit this process ([@bib35], [@bib42]). Given that Nodal induces transcription of Fgf ligands in the first two cell tiers, these cells must be exposed to high levels of Fgf ([@bib58]). Thus, how endoderm is specified in a domain with active Nodal and Fgf signaling remains unsolved.

In this paper we solve this paradox and propose a model for endoderm and mesoderm specification. We demonstrate that it is the Ras/Erk pathway downstream of the Fgf receptors that is responsible for inhibiting endoderm specification. We go on to show that Nodal induces long-range Fgf signaling in the zebrafish margin, while simultaneously inducing an inhibitor of phosphorylated Erk1/2 in the first two cell tiers from the YSL. This incoherent feedforward motif explains the separation of the mesoderm and endoderm lineages.

Results {#sec2}
=======

Erk1/2 Signaling Downstream of Fgf Inhibits Endoderm Specification {#sec2.1}
------------------------------------------------------------------

To understand how Nodal and Fgf signaling interact during endoderm specification, we first determined the relative spatial organization of endodermal progenitors and *fgf* ligand expression within the lateral margin using whole-mount *in situ* hybridization (WISH) and sectioning. At 50% epiboly (5.3 hpf), *sox32*-positive endodermal progenitors are detected predominantly in the first two cell tiers, intermingled with *sox32*-negative cells ([Figures 1](#fig1){ref-type="fig"}A and 1B). At this stage, *fgf3* and *fgf8a* are expressed in four to five cell tiers from the YSL, overlapping the domain where the *sox32*-positive cells are found ([Figure 1](#fig1){ref-type="fig"}C). Besides expression in the blastoderm, *fgf3* expression is also found in the YSL. Both *fgf3* and *fgf8a* could be readily induced by recombinant human NODAL in dissociated embryonic cells, supporting the view that Fgf ligand expression in the margin is Nodal dependent ([@bib4], [@bib34]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Thus, endodermal progenitors are specified in a domain that expresses *fgf* ligands, which are induced by Nodal.Figure 1Endoderm Progenitors Arise in an Fgf Ligand-Expressing Domain, but Their Specification Is Inhibited by Fgf Signaling(A) Representative image of a 50% epiboly (5.3 hpf) embryo stained for *sox32* by WISH.(B) Sections of three 50% epiboly embryos stained for *sox32* by WISH. Dashed line represents the border of the YSL and blastoderm, and arrows indicate *sox32*-positive endoderm progenitors. Scale bar, 25 μm.(C) Sections of 50% epiboly embryos stained for *fgf3* and *fgf8a*. Note that *fgf3* is also expressed in the YSL. Scale bar, 25 μm.(D) Images of 75% epiboly (8 hpf) zebrafish embryos treated with DMSO or PD-0325901 from sphere stage, stained for *sox17* by WISH. Arrowhead indicates dorsal forerunner cells to aid comparison of stages.(E) Quantification of *sox17-*positive cells in embryos as in (D) treated with DMSO (d), SU-5402 (SU), or PD-0325901 (PD). Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.(F) Quantification of *sox17*-positive cells at 90% epiboly after treatment with DMSO (d) or PD-0325901 (PD) from sphere (s), 30% epiboly (30), or 50% epiboly (50), corresponding to 4, 4.7, and 5.3 hpf, respectively. Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.(G) qPCR for indicated genes in dissociated embryonic cells treated with recombinant human NODAL and/or bFGF. Means ±SEM, n = 3, t test; ^∗^p \< 0.05.(H) Double fluorescence *in situ* hybridization (FISH) for *lft2* and *sox32* in flat-mounted 50% epiboly embryos treated with DMSO or PD-0325901. White box indicates enlargement in right panel and dotted line marks the boundary between the YSL and margin.(I) Graph of quantification of *sox32*-positive cells in (H). Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.Scale bars, 100 μm unless otherwise stated. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

We next addressed the timing of the inhibitory effects of Fgf on endoderm formation in a quantitative manner. By 75% epiboly (8 hpf), a single population of involuted endodermal progenitors express *sox32*, *foxa2*, and *sox17*, and migrate away from the margin ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). We have subsequently used *sox17* WISH at 75% epiboly to quantitate endodermal progenitor numbers following manipulation of Fgf signaling. Overexpression of *fgf8a* mRNA reduced the number of endoderm progenitors, whereas inhibition of Fgf signaling from the 16-cell stage, using the Fgf receptor inhibitor SU-5402, increased their number ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E) ([@bib35], [@bib36], [@bib42]). Prior to their expression in the margin, the Fgf ligands are expressed dorsally ([@bib18]). Since inhibition of dorsal Fgf signaling before sphere stage could potentially disrupt dorsal-ventral patterning, leading to secondary effects on endoderm specification ([@bib42], [@bib48]), we tested the effects of inhibiting Fgf signaling from sphere stage onward. This also resulted in an increase in endodermal progenitors, indicating that Fgf signaling inhibits endoderm formation after sphere stage and thus acts directly on cells of the ventral/lateral margin ([Figure S1](#mmc1){ref-type="supplementary-material"}F).

Given that Erk1/2-mediated Fgf signaling is activated downstream of Nodal in the margin, we asked whether the inhibitory effect of Fgf on endoderm formation was dependent on Erk1/2 ([@bib42], [@bib58]) using the Mek1/2 inhibitor PD-0325901 to block the Ras-Erk1/2 signaling pathway ([@bib2]). This inhibitor is fast acting and reduces P-Erk to almost negligable levels within 20 min of addition ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H). Incubation with PD-0325901 from sphere stage increased endodermal progenitor numbers at 75% epiboly by approximately 40%, confirming that the effects were Erk1/2 dependent ([Figures 1](#fig1){ref-type="fig"}D and 1E). We then investigated the timing of the inhibitory effect using PD-0325901, and showed that the number of endoderm progenitors could only be increased if Mek1/2 was inhibited before 50% epiboly ([Figure 1](#fig1){ref-type="fig"}F). This narrowed the time window in which Fgf signaling inhibits endoderm formation to between sphere and 50% epiboly, and suggested that the effect was at the level of transcriptional activation of the endodermal master regulators. Indeed, in dissociated embryonic cells, recombinant basic FGF (bFGF) inhibited NODAL-induced expression of *sox32*, *foxa2*, and *gata5* ([Figure 1](#fig1){ref-type="fig"}G). As a positive control we used the Nodal target gene *lft2*, which we previously showed was inhibited by Fgf signaling ([@bib58]). In contrast, expression of the mesodermal transcription factors *ta* and *noto* was induced by bFGF, indicating that they are Fgf target genes (see below).

To confirm that the negative effect of Fgf signaling on endoderm formation was directly at the level of specification, we quantitated endodermal progenitor cell numbers at 50% epiboly using fluorescence *in situ* hybridization (FISH) for *sox32* and *lft2* ([@bib12], [@bib26]). We used *lft2* as a control because it is expressed exclusively in the first two cell tiers from the margin ([@bib58]), thus allowing us to distinguish *sox32*-positive endoderm progenitors from the YSL ([Figure 1](#fig1){ref-type="fig"}H). Inhibition of Fgf signaling from sphere stage by PD-0325901 or SU-5402 increased numbers of *sox32*-postive cells at 50% epiboly, as well as the number of *lft2*-positive cells ([Figures 1](#fig1){ref-type="fig"}H and 1I). Taken together, our data demonstrate that Fgf signaling, through the Ras-Raf-Mek1/2-Erk1/2 pathway, inhibits specification of endoderm progenitors between sphere and 50% epiboly stages. This is likely at the expense of mesoderm, as Fgf inhibition decreases mesoderm progenitors marked by *ta* ([@bib58]).

Erk1/2-Mediated Fgf Signaling Is Inhibited in the First Two Cell Tiers {#sec2.2}
----------------------------------------------------------------------

Given that *fgf* ligands are induced by Nodal in the first four to five cell tiers from the YSL, and that Erk1/2-mediated Fgf signaling represses endoderm specification, it is remarkable that endoderm is specified in the first two cell tiers at all. To gain insight into this problem, we determined the relative levels of Nodal and Fgf signaling within the margin at 50% epiboly. To this end, we used immunohistochemistry for P-Smad2 and P-Erk, respectively, and quantitated staining intensities within the first ten cell tiers of the margin. As shown previously, nuclear P-Smad2 staining extended up to four to five cell tiers, with highest levels in the first two cell tiers ([Figures 2](#fig2){ref-type="fig"}A and 2B) ([@bib15], [@bib58]). In contrast, nuclear P-Erk staining extended up to around nine to ten cell tiers, but crucially was relatively low in the first two cell tiers compared with the third and fourth cell tiers ([Figures 2](#fig2){ref-type="fig"}A and 2C). Imaging of flat-mounted embryos or using light-sheet microscopy resulted in identical spatial signaling patterns, which excluded possible imaging artifacts ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). These experiments demonstrated that levels of Erk1/2-mediated Fgf signaling were relatively low at 50% epiboly in the two cell tiers closest to the YSL.Figure 2Cells Adjacent to the YSL Exhibit Low Levels of P-Erk(A) Z-Projection of the margin of a 50% epiboly embryo stained for P-Erk and P-Smad2. Dashed line indicates the boundary between the YSL and the margin. Scale bar, 50 μm.(B) Quantification of three embryos stained for P-Smad2 as in (A). Depicted is the mean ± SD from a representative experiment (n \> 3).(C) As in (B) for P-Erk.(D) Animal views of WISH-stained 50% epiboly embryos for *noto*, treated with the Fgf signaling inhibitor (SU-5402) or the Nodal signaling inhibitor (SB-505124). Note that the inhibition of *noto* expression by SB-505124 reflects the regulation of Fgf by Nodal. Scale bar, 100 μm.(E) Quantification of unsaturated FISH-stained embryos for *lft2* and *noto* at 50% epiboly. For each trace n = 3, means are shown by the lines, and the shading indicates the SD.(F) As in (E), but for *lft2* and *ta*.(G) Sections of unsaturated WISH-stained embryos for *lft2*, *ta*, and *noto*. Arrows indicate cells with low levels of expression and dashed line marks the border of the YSL. Scale bar, 25 μm.(H) Schematic representation of gene expression in the margin.(I) Time course of weighted means of P-Erk staining intensities, normalized to DAPI in the margin from 4 hpf (sphere stage) to 5 hpf (40% epiboly).(J) As in (I), but for P-Smad2.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We also investigated whether Fgf target gene expression followed a similar spatial distribution pattern as P-Erk. For this experiment we focused on *ta* and *noto*. We previously showed that the *ta* expression beyond the Nodal signaling domain is Fgf dependent ([@bib58]), and we confirmed that the lateral and ventral expression of *noto* is also entirely dependent on Fgf signaling, since it is inhibited by the Fgf receptor inhibitor SU-5402 ([Figure 2](#fig2){ref-type="fig"}D). Staining of 50% epiboly embryos for *ta* and *noto* using FISH, followed by quantification in the margin of flat-mounted embryos, revealed that the expression levels of both genes were lower in the two cell tiers closest to the YSL, which correlated well with the observed P-Erk pattern ([Figures 2](#fig2){ref-type="fig"}E and 2F). In contrast, *lft2* expression levels peaked in the first two cell tiers. Identical patterns were evident in sections of the ventral and lateral margin from *lft2*, *ta*, and *noto* unsaturated WISH-stained embryos at 50% epiboly ([Figures 2](#fig2){ref-type="fig"}G, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D). These experiments showed that *sox32*-positive endoderm progenitors are specified within a low P-Erk domain, which extends two cell tiers from the YSL, and is marked by *lft2*. *noto* and *ta* expression is predominantly induced in a high P-Erk domain, from about two to ten cell tiers ([Figure 2](#fig2){ref-type="fig"}H). Our data strongly suggest that Fgf signaling is specifically inhibited in the first two cell tiers, thus allowing endoderm specification.

We then focused on the mechanism underlying the low P-Erk levels in the first two cell tiers. Since Erk1/2-mediated Fgf signaling is highly dynamic, we reasoned that rapid negative feedback within the pathway might explain the low levels of P-Erk in the first two cell tiers. We therefore examined how the Fgf signaling domain evolved during the time period in which endoderm is specified, in particular, between sphere (4 hpf) and 40% epiboly (5 hpf). During this period, the positions of cells within the margin do not change extensively ([@bib15]). Quantitative imaging of P-Erk staining in this time period demonstrated that Fgf signaling expanded rapidly to about nine cell tiers ([Figure 2](#fig2){ref-type="fig"}I). Crucially, in the first two cell tiers, P-Erk levels also increased over time, but to a lesser extent compared with the third and fourth cell tiers. Over the same period, Nodal signaling, readout by P-Smad2, gradually expanded away from the YSL to about four cell tiers ([Figure 2](#fig2){ref-type="fig"}J). From this analysis, we concluded that the first two cell tiers were relatively unresponsive to Fgf ligands compared with cells further away.

Nodal and Fgf can Induce Endoderm and Mesoderm Progenitors at the Animal Pole {#sec2.3}
-----------------------------------------------------------------------------

We reasoned that the low responsiveness of the first two cell tiers to Fgf ligands could be due to their position adjacent to the YSL. For instance, the YSL could potentially secrete Fgf antagonists, or there could be differences in the extracellular matrix composition of these cells. However, we ruled out this possibility as *sox32*-positive endodermal cells are readily induced at the animal pole when a Nodal (Ndr1)-expressing clone was introduced at the 128-cell stage and the embryos were allowed to develop to germ ring stage (5.7 hpf) ([Figures 3](#fig3){ref-type="fig"}A, 3B, and [S3](#mmc1){ref-type="supplementary-material"}A) ([@bib10], [@bib42], [@bib45]). This demonstrates that endoderm specification is independent of the position relative to the YSL, but instead is part of a patterning event downstream of Nodal. Strikingly, we found that endodermal cells were specified within a *lft2*-expressing domain, whereas *noto* and *ta* were expressed at higher levels outside the *lft2* domain, mimicking the spatial organization of mesoderm and endoderm progenitors at the margin ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}A--S3C). This predicted that Fgf signaling was also activated downstream of Nodal surrounding these clones and, indeed, we could demonstrate that transcription of both *fgf3* and *fgf8a* is induced ([Figures 3](#fig3){ref-type="fig"}C, [S3](#mmc1){ref-type="supplementary-material"}D, and S3E). Moreover, we observed activation of both Nodal and Fgf signaling surrounding the clones by staining for P-Smad2 and P-Erk, respectively ([Figure 3](#fig3){ref-type="fig"}D). We observed that a subset of P-Smad2-positive cells exhibited low levels of nuclear P-Erk staining. Furthermore, in some dense clones, Nodal expression gave rise to a domain of low P-Erk staining in the center, although in most clones this was not the case, likely due to the inherent dispersion of the Nodal-expressing cells between the 128-cell and germ ring stage ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). In conclusion, patterning surrounding Nodal-expressing clones recapitulates the patterning at the margin ([Figures 3](#fig3){ref-type="fig"}E and [2](#fig2){ref-type="fig"}H).Figure 3Ectopic Nodal-Induced Patterning at the Animal Pole Mimics Patterning at the Margin(A) Schematic of generation of Ndr1-expressing clones. Single blastomeres are injected at the 128-cell stage (2.25 hpf), fixed at germ ring stage (5.7 hpf) and stained using FISH or immunohistochemistry.(B) Animal views of germ ring-stage embryos containing Ndr1-expressing clones marked with dextran-fluorescein (dex) and stained for indicated markers.(C) As in (B), but for *fgf3* and *fgf8a*.(D) Germ ring-stage embryos containing Ndr1-expressing clones, stained by immunohistochemistry for P-Erk and P-Smad2. Single panels are shown and a merge. The merge on the far right shows the Ndr1-expressing cells labeled with dex (white) with staining for P-Smad2 (green).(E) Schematic representation of gene expression in surrounding Ndr1-expressing clones.Scale bars, 100 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

We reasoned that, for endoderm to be specified ectopically at the animal pole, the regulatory mechanism that suppressed Fgf signaling also must operate within and surrounding Nodal-expressing clones. We tested this hypothesis by generating Ndr1-expressing clones and incubating the embryos with PD-0325901, followed by quantification of *sox32*-positive endodermal cell numbers at germ ring stage. This clearly demonstrated that inhibition of Fgf signaling led to an increased number of endodermal progenitors around the Ndr1-expressing clones ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S4](#mmc1){ref-type="supplementary-material"}A). Simultaneously, PD-0325901 expanded the size of the *lft2* domain and reduced the expression of the mesodermal markers *ta* and *noto* ([Figures 4](#fig4){ref-type="fig"}C--4E, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). Thus, the signaling events initiated by Ndr1 expression in the animal pole recapitulate the signaling events that underlie patterning of mesoderm and endoderm progenitors at the margin.Figure 4Fgf Signaling Represses Endoderm Specification around Ndr1 Clones(A) Animal views of DMSO- and PD-0325901-treated germ ring-stage embryos containing Ndr1-expressing clones stained for *lft2* and *sox32*.(B) Quantification of *sox32*-positive cells in (A). Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.(C) Quantification of surface area of *lft2*-positive domain surrounding Ndr1-expressing clones in embryos treated as in (A). n = 3, 11 embryos in total. Means ± SD, two-tailed t test; ^∗^p \< 0.05.(D) Animal views of germ ring-stage embryos treated as in (A), but stained for *ta* and *lft2*.(E) Animal views of germ ring-stage embryos treated as in (A), but stained for *noto* and *lft2*.Scale bars, 100 μm. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Dusp4 Is a Direct Nodal Target and Dephosphorylates P-Erk {#sec2.4}
---------------------------------------------------------

We hypothesized that, for levels of P-Erk to remain low in the first two cell tiers over time, Nodal could simultaneously induce the transcription of *fgf* ligands, as well as an intracellular inhibitor of the Ras-Raf-Mek1/2-Erk1/2 pathway. Interestingly, two dual specificity phosphatases, Dusp4 and Dusp6, which are known to dephosphorylate Erk1/2 in different contexts, are expressed in the margin between the sphere and 50% epiboly stages ([Figure S5](#mmc1){ref-type="supplementary-material"}A) ([@bib4], [@bib9], [@bib21]). We focused on Dusp4 since it is a nuclear phosphatase, whereas Dusp6 is cytoplasmic ([@bib9]). Dusp4 has also previously been implicated as a regulator of endoderm formation in zebrafish ([@bib8]). Sectioning of WISH-stained embryos revealed that *dusp4* is expressed in the dorsal YSL and in the first two cell tiers of the ventral and lateral margin at 50% epiboly ([Figure 5](#fig5){ref-type="fig"}A). To determine whether *dusp4* is regulated by Nodal or Fgf signaling *in vivo*, we inhibited the pathways with SB-505124 or SU-5402, respectively, and analyzed spatial expression by WISH. For comparison, we also analyzed the expression of *dusp6*, which is known to be regulated by Fgf signaling ([@bib37]). Inhibition of Nodal signaling completely abolished the expression of *dusp4* in the margin, while expression in the YSL was unaffected ([Figure 5](#fig5){ref-type="fig"}B). This was not an indirect effect through activation of Fgf signaling, since SU-5402 did not affect the size of the *dusp4* expression domain. In contrast, *dusp6* expression was severely reduced when embryos were treated with SU-5402, but to a lesser extent when treated with SB-505124, likely because of Fgf production by the YSL ([Figures 5](#fig5){ref-type="fig"}B and [1](#fig1){ref-type="fig"}C). Moreover, in dissociated embryonic cells, we found that *dusp4*, but not *dusp6,* expression was dose dependently induced by NODAL ([Figure 5](#fig5){ref-type="fig"}C). To confirm that *dusp4* is a direct Nodal target gene, we identified two potential enhancer regions (r1 and r2) upstream of the *dusp4* transcriptional start site (TSS) ([Figure S5](#mmc1){ref-type="supplementary-material"}B) and performed chromatin immunoprecipitation for Smad2. Both the r1 and r2 genomic regions, but not the TSS, were bound by Smad2 in a Nodal signaling-dependent manner, similar to a known enhancer site upstream of the Nodal target gene *mixl1* (also called *mixer* or *bon*) ([@bib39]) ([Figure 5](#fig5){ref-type="fig"}D). Furthermore, it was recently reported that Mixl1 was enriched together with Smad2 at site r2 ([@bib38]) ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Consistent with this, we could demonstrate that expression of *dusp4* was dependent on Mixl1, whereas expression of *lft1*, used as a control, was not ([Figures 5](#fig5){ref-type="fig"}E and 5F). Thus, *dusp4* is induced by Nodal via a so-called self-enabling mechanism, where Nodal induces the expression of a transcription factor (Mixl1), which then binds with Smad2 to induce transcription of the target gene ([@bib23]). *dusp4* was also induced in and around the Nodal-expressing clones in the animal pole ([Figures 5](#fig5){ref-type="fig"}G and [S5](#mmc1){ref-type="supplementary-material"}C).Figure 5Zebrafish Dusp4 Is a Direct Nodal Target, Expressed in the First Two Cell Tiers, that Dephosphorylates Erk(A) Sagittal and lateral sections of 50% epiboly embryo WISH-stained for *dusp4*.(B) WISH at 50% epiboly for *dusp4* and *dusp6* after Nodal signaling inhibition (SB-505124) or Fgf signaling inhibition (SU-5402).(C) qPCR using dissociated embryonic cells treated with increasing NODAL concentrations. Means ± SEM, n = 5.(D) Chromatin immunoprecipitation for Smad2 on putative enhancers of the *dusp4* gene (r1 and r2) and the *dusp4* transcription start site (TSS) in 50% epiboly embryos treated with DMSO or the Nodal receptor inhibitor SB-505124. The *mixl1* TSS and *sox10* TSS are positive and negative controls respectively. Means ± SEM, n = 4, ^∗^p \< 0.05, t test.(E and F) 50% epiboly zebrafish embryos injected with control MO (con MO) or *mixl1* MO, stained for *dusp4* (E) or *lft1* (F) by WISH.(G) Animal view of germ ring-stage embryo containing Ndr1-expressing clone, marked with dextran-fluorescein (dex) and stained for *dusp4.*(H) Western blot showing attenuation of Fgf8a-induced P-Erk by Dusp4 at 50% epiboly.(I) Quantification of embryos stained by FISH for *dusp4* at 4.3 (dome), 4.7, and 5.0 hpf. For each time point n = 3, means are shown by the lines and the shading indicates the SD.(J) A confocal Z-reconstruction of a 50% epiboly embryo stained for *dusp4* and *sox32.* Nuclei are marked by DAPI. Arrow indicates a cell in the blastoderm labeled with both *dusp4* and *sox32*. Dashed white line indicates the border of the YSL. Scale bar, 25 μm.Scale bars, 100 μm unless otherwise stated. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

To confirm that zebrafish Dusp4 can dephosphorylate P-Erk *in vivo* we injected *fgf8a* mRNA with or without *dusp4* mRNA and performed western blotting for P-Erk. This demonstrated that Dusp4 attenuates the phosphorylation of Erk ([Figure 5](#fig5){ref-type="fig"}H). This was also evident from analysis of *ta* expression using WISH in embryos from the same experiment, where Fgf8a-induced expression of *ta* was attenuated by Dusp4 ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Finally, high-resolution quantitative analysis of *dusp4* expression over time revealed that *dusp4* was first detected at 4.7 hpf, and by 5 hpf (around 40% epiboly) was localized predominantly in the first two cell tiers, co-localizing with *sox32* ([Figures 5](#fig5){ref-type="fig"}I, 5J, and [S5](#mmc1){ref-type="supplementary-material"}E). In conclusion, *dusp4* is a direct Nodal target gene that attenuates P-Erk-mediated Fgf signaling and is expressed in the first two cell tiers, correlating with the low P-Erk levels observed in these cells.

Dusp4 Loss of Function Reduces Endodermal Progenitor Numbers and Increases Fgf Signaling in the Margin {#sec2.5}
------------------------------------------------------------------------------------------------------

If Dusp4 was responsible for attenuating P-Erk in the first two cell tiers to allow blastomeres to be specified as endoderm, loss of function should result in increased levels of Fgf signaling and reduced endodermal progenitor numbers at 50% epiboly. To determine the effects of Dusp4 depletion, we used a start site morpholino (MO) and two non-overlapping splice-blocking MOs directed against *dusp4* ([Figure S6](#mmc1){ref-type="supplementary-material"}A) ([@bib8]). When injected in one- to two-cell-stage embryos, all three MOs resulted in a reduction of *sox17*- and *foxa2*-positive cells of up to 60% at 75% epiboly ([Figures 6](#fig6){ref-type="fig"}A--6C and [S6](#mmc1){ref-type="supplementary-material"}B--S6D). Importantly, co-injection of each *dusp4* MO with capped *dusp4* mRNA partially rescued endodermal progenitor numbers, demonstrating their specificity ([Figures S6](#mmc1){ref-type="supplementary-material"}E and S6F). In contrast, knock down of *dusp6* did not result in a difference in endodermal cell numbers ([Figures S6](#mmc1){ref-type="supplementary-material"}G--S6J). To directly determine the effects of *dusp4* knockdown on attenuation of Fgf signaling, we used WISH and qPCR for *noto* as an integrated Fgf signaling readout. Both experiments showed that the loss of *dusp4* led to higher levels of *noto* expression in the margin at 50% epiboly ([Figures 6](#fig6){ref-type="fig"}D, 6E, [S6](#mmc1){ref-type="supplementary-material"}K, and S6L). Finally, since Ndr1-expressing clones induced endoderm specification and *dusp4* was expressed surrounding these clones, the levels of *dusp4* should also control ectopic endodermal cell numbers at the animal pole. Therefore, we generated Ndr1-expressing clones in *dusp4* mRNA-injected embryos and quantitated the number of endodermal cells surrounding these clones at germ ring stage. Indeed, Dusp4 overexpression led to more endoderm progenitors being induced ([Figures 6](#fig6){ref-type="fig"}F, 6G, and [S6](#mmc1){ref-type="supplementary-material"}M). From these experiments, we concluded that Dusp4 regulates endoderm specification by attenuating Fgf signaling in the first two cell tiers.Figure 6Dusp4-Mediated Repression of Fgf Signaling Is Required for Endoderm Specification(A) Representative images of 75% epiboly zebrafish embryos injected with control MO (con MO) or *dusp4* MO3, stained for *sox17* by WISH. Arrowhead indicates dorsal forerunner cells for comparison of staging.(B) As in (A), but stained for *foxa2*. Arrow, *foxa2* expression in axial mesoderm.(C) Quantification of endodermal progenitors in 75% epiboly embryos, injected with indicated *dusp4* MOs. Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.(D) qPCR on 50% epiboly embryos injected with control MO or *dusp4* MOs. Means ± SEM, n ≥ 2, t test; ^∗^p \< 0.05.(E) Traces of *noto* expression detected with FISH in 50% epiboly zebrafish embryos injected with control MO or *dusp4* MO3. For each condition, n = 3. Means are shown by the lines and the shading indicates the SD.(F) Animal views of germ ring-stage embryos, control-injected or injected with *dusp4* mRNA, containing Ndr1-expressing clone and stained for *lft2* and *sox32*.(G) Quantification of *sox32*-positive cells as in (F). Means ± SD, Mann-Whitney U test; ^∗^p \< 0.05.Scale bars, 100 μm. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

An Incoherent Feedforward Motif Is Required for the Specification of Endoderm versus Mesoderm {#sec3.1}
---------------------------------------------------------------------------------------------

Here we describe a mechanism for the separation of the mesodermal and endodermal lineages in the zebrafish, and show that it is not explained by a single morphogen gradient. We provide strong evidence that Nodal triggers a feedforward patterning system, which combines long-range signal activation with local inhibition. Our data demonstrate that Nodal simultaneously induces the expression of secreted Fgf ligands and the cell-autonomous Fgf signaling inhibitor Dusp4 ([Figure 7](#fig7){ref-type="fig"}A). This type of wiring pattern has previously been named as an incoherent feedforward motif ([@bib32]), and is widespread in gene regulatory networks, but less known in the context of signaling.Figure 7Model for Meseoderm and Endoderm Lineage Separation through an Incoherent Feedforward Motif(A) Wiring diagram for spatial patterning at the margin.(B) Schematic of growing domains of Nodal and Fgf signaling and *dusp4* expression. Intensity of color reflects signaling levels. Endoderm can be specified in the first cell tiers because of accumulating Nodal signaling, which attenuates Erk-mediated Fgf signaling via Dusp4. Mesoderm is specified by Fgf signaling ± Nodal signaling.

Nodal signaling in the ventral and lateral margin is initiated by the production of Ndr1/2 in the YSL, which induces Nodal signaling in the blastoderm, leading to expression of *ndr1/2* in these cells and subsequent spreading of signaling away from the YSL. The consequence of this temporal gradient is that cells in the first two cell tiers experience the longest duration of Nodal signaling. As a result, they exhibit the highest levels of P-Smad2, because the P-Smad2 signal is integrated over time ([@bib58]). When Nodal signaling is initiated in the blastoderm, it induces the expression of Fgf ligands, which results in a broad domain of P-Erk activity, up to ten cell tiers. Nodal concurrently induces the expression of the intracellular P-Erk antagonist Dusp4 in the first two cell tiers. Taken together, this results in a pattern where the most marginal cells in tiers 1 and 2 exhibit lower levels of P-Erk compared with cells in tiers 3 and 4, despite being exposed to high levels of Fgf ligands. Cells in the first two cell tiers are therefore protected from the repressive effects of Fgf signaling, experience sustained Nodal signaling, and can thus be specified as endoderm ([Figure 7](#fig7){ref-type="fig"}B). Cells further away from the YSL experience higher levels of Erk1/2-mediated Fgf signaling and are specified as mesoderm. We have therefore uncovered a system in which a group of cells are instructed to produce a signaling molecule that they themselves are insensitive to, but which can alter the fate of their neighbors.

The Importance of the Dynamics of Fgf and Nodal Signaling in the Specification of Endoderm versus Mesoderm {#sec3.2}
----------------------------------------------------------------------------------------------------------

Although Nodal signaling clearly modulates Fgf signaling in the zebrafish margin via the induction of Dusp4, we have found no evidence in this system for a direct effect of Fgf signaling on Nodal signaling. Inhibition of Fgf signaling with the receptor inhibitor SU-5402 has no effect on the expression of the Nodal target gene *lft1*, or on the levels of activated P-Smad2 ([@bib58]). Moreover, inhibition of Fgf signaling had no effect on Smad2 linker phosphorylation, which can be induced by Erk1/2 in some contexts ([@bib19], [@bib30]) (our unpublished data).

Our data show that attenuation of P-Erk by Nodal-induced Dusp4 is required for endoderm specification, but it is evidently not sufficient as most cells in the first two cell tiers express *dusp4* by 50% epiboly, but not all are specified as endoderm. It is therefore likely that additional mechanisms regulate the stochastic induction of endoderm progenitors at the margin. We have observed that *sox32* expression occurs randomly within the first two cell tiers of the margin, arguing against a lateral inhibition-type mechanism. We speculate that there may be inherent noise in the P-Erk signal, as recent reports have demonstrated stochastic Erk activation pulses in response to growth factors ([@bib3]). Live imaging of P-Erk will be required to explore this further. Another possibility is that other signaling pathways are involved in generating the salt and pepper pattern of *sox32*-postive cells.

In addition to the role that Fgf signaling plays in stochastic induction of endoderm at the margin, the extended duration of Nodal signaling is also crucial ([@bib22], [@bib47]). The mechanistic reason for endoderm specification requiring extended Nodal signaling may lie in the downstream transcription factor network necessary for *sox32* induction. Transcriptional activation of *sox32* requires a combination of the transcription factors Mixl1, Gata5 (also called Fau), Mezzo, and Eomesa ([@bib6], [@bib14], [@bib27], [@bib38], [@bib43], [@bib44]). Importantly, transcription of *mixl1, gata5*, and *mezzo* requires Nodal signaling ([@bib27], [@bib43], [@bib44]). This would introduce a short delay in the induction of *sox32* relative to other direct Nodal-induced genes, and thus could explain the requirement for prolonged Nodal signaling.

Another key finding is the restriction of *dusp4* expression to the first two cell tiers at 50% epiboly. Interestingly, *lft2* is also restricted to these cell tiers and we have shown that this is due to inhibition of its transcription by Fgf signaling ([@bib58]). We can rule out this mechanism for *dusp4*, however, as its expression domain does not expand when Fgf signaling is inhibited. One contributing factor in the restricted expression of *dusp4* may be a delay in its transcription. We observe that the domain of *dusp4* expression grows slowly relative to other Nodal targets, being readily detected only at 40% epiboly (5 hpf), compared with genes such as *lft1* and *lft2*, which are expressed in the margin from about dome stage (4.3 hpf) ([@bib58]). Further work will be required to fully elucidate the mechanism.

Our experiments also reveal that the negative effect of Erk1/2-mediated Fgf signaling on endoderm induction is at the level of *sox32* transcription. However, we do not yet know the identity of the targets of Erk phosphorylation that explains this. A possible mechanism could involve one of the transcriptional activators of *sox32* being negatively regulated by Erk phosphorylation. However, Mixl1 and Gata5 are unlikely targets as the loss of *sox32*-positive endodermal progenitors in *bon* and *fau* mutants can be partially rescued by inhibition of Fgf signaling ([@bib35]). An alternative mechanism could be the involvement of a transcriptional repressor of s*ox32,* which is positively regulated by Erk phosphorylation.

Fgf Signaling Is Required for Mesoderm Specification {#sec3.3}
----------------------------------------------------

Our work provides evidence for an essential role for Fgf signaling in the specification of mesoderm. From our immunostainings for P-Smad2 and P-Erk, it is evident that some cells specified as mesoderm receive a combination of Nodal and Fgf signaling, while others, further from the YSL, experience only Fgf signaling ([Figure 7](#fig7){ref-type="fig"}B). We previously demonstrated that expression of mesodermal markers, beyond the Nodal signaling domain of five cell tiers, for example *ta*, is induced by Fgf signaling ([@bib58]). We now show that the expression of another crucial transcription factor for mesoderm induction, Noto, is also induced by Fgf signaling in the same domain ([@bib54]). Similarly, generation of Nodal-expressing clones in the animal pole leads to Fgf signaling-dependent transcription of mesodermal transcription factors *ta* and *noto*. It is likely that the relative levels of Nodal and Fgf signaling within the margin pattern the mesoderm further at later time points, although the details of this remain to be worked out.

Concluding Remarks {#sec3.4}
------------------

This study reveals the importance of feedforward and feedback loops involving multiple dynamic signaling pathways in spatial patterning, rather than single morphogen gradients. Previous models of mesoderm and endoderm specification have focused on the role of graded Nodal signaling to confer positional information. Our work now demonstrates that it is the interplay between Nodal and downstream Fgf signaling that provides this information in the developing embryo, and determines which cells are competent to become endoderm progenitors, and which mesoderm. Our proposed mechanism thus explains how graded Nodal signaling can induce two non-overlapping cell fates, and it is the transcription boundary of the inhibitor (Dusp4) that defines the position of the boundary between them. These findings will form the basis for further investigations into embryonic patterning, but also in directed differentiation of embryonic stem cells for use in regenerative medicine. Indeed, in micro-patterned human embryonic stem cell colonies, a ring of *SOX17*-expressing cells is formed within the domain of active NODAL signaling cells, but is mutually exclusive from an inner ring of P-ERK-positive cells that express *T* ([@bib52], [@bib61]). This suggests that lessons learned from the zebrafish may be directly applicable to mammalian systems.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-phospho-Smad2 (IF)Cell Signaling TechnologyCat\# 8828; RRID: [AB_2631089](nif-antibody:AB_2631089){#intref0010}Anti-phospho-Erk (IF and Western)SigmaCat\# M8159; RRID: [AB_477245](nif-antibody:AB_477245){#intref0015}Anti-Digoxigenin-AP (*in situ*)RocheCat\# 11093274910; RRID: [AB_514497](nif-antibody:AB_514497){#intref0020}Anti-Digoxigenin-HRP (*in situ*)RocheCat\# 1207733910Anti-DNP-HRP (*in situ*)Perkin ElmerCat\# FP1129; RRID: [AB_2629439](nif-antibody:AB_2629439){#intref0025}Anti-DNP-AP (*in situ*)Vector LaboratoriesCat\# MB-3100; RRID: [AB_2336089](nif-antibody:AB_2336089){#intref0030}Anti-Rabbit Alexa Fluor 488 (IF)Thermo Fisher ScientificCat\# A-21206; RRID: [AB_2535792](nif-antibody:AB_2535792){#intref0035}Anti-Mouse Alexa Fluor 546 (IF)Thermo Fisher ScientificCat\# A-10036; RRID: [AB_2534012](nif-antibody:AB_2534012){#intref0040}Anti-Mouse Alexa Fluor 594 (IF)Thermo Fisher ScientificCat\# A-21203; RRID: [AB_2535789](nif-antibody:AB_2535789){#intref0045}Anti-Rabbit Alexa Fluor 647 (IF)Thermo Fisher ScientificCat\# A-21244; RRID: [AB_10562581](nif-antibody:AB_10562581){#intref0050}Anti-Mouse-HRP (Western)DakoCat\# P0447;\
RRID: [AB_2617137](nif-antibody:AB_2617137){#intref0055}Anti-Rabbit-HRP (Western)DakoCat\# P0448;\
RRID: [AB_2617138](nif-antibody:AB_2617138){#intref0060}Anti-Erk1 (Western)Santa CruzCat\# sc-94; RRID: [AB_2140110](nif-antibody:AB_2140110){#intref0065}Anti-Actin (Western)SigmaCat\# A3853; RRID: [AB_262137](nif-antibody:AB_262137){#intref0070}Anti-Smad2 (31H15L4) (ChIP)Thermo Fisher ScientificCat\# 700048; RRID: [AB_2532277](nif-antibody:AB_2532277){#intref0075}Anti-Smad2 (D43B4) (ChIP)Cell Signaling TechnologyCat\# 5339; RRID: [AB_10626777](nif-antibody:AB_10626777){#intref0080}**Chemicals, Peptides, and Recombinant Proteins**SB-505124SigmaCat\# S4696SU-5402MerckCat\# 572631PD-0325901MerckCat\# 444968NBT/BCIP tabletsSigmaCat\# B5655Fast Red TR/Naphthol AS-MX TabletsSigmaCat\# F4648Tyramine hydrochlorideSigmaCat\# T2879NHS-Fluorescein esterThermo Fisher ScientificCat\# 46410Cy5 Mono NHS esterSigmaCat\# PA51501Human recombinant NODALR&DCat\# 3218-ND/CFHuman basic FGFPeprotechCat\# AF100-18b**Critical Commercial Assays**QuikChange XL Site-Directed Mutagenesis KitAgilentCat\# 200516**Experimental Models: Organisms/Strains**Zebrafish *Danio rerio*: WTN/AN/A**Oligonucleotides**See [Table S1](#mmc2){ref-type="supplementary-material"} for list of all primers, cloning oligonucleotides and morpholinosThis studyN/A**Recombinant DNA**pBKS-*ntl-a*: probe synthesis *ta*: linearize Xho1: polymerase T7[@bib50]N/ApAD-gal4-*Lft2*: probe synthesis *lft2*: linearize Mlu1: polymerase T7[@bib5]N/ApBSK-*flh*: probe synthesis *noto*: linearize EcoR1: polymerase T7[@bib54]N/ApBSK-*fgf3*: probe synthesis *fgf3*: linearize BamH1: polymerase T7[@bib25]N/ApBSK-*fgf8a* (cb110): probe synthesis *fgf8a*: linearize Not1: polymerase T7<https://zfin.org/ZDB-PUB-010810-1>\
ZFIN online publicationN/ApBKS-*sox17*: probe synthesis *sox17*: linearize Nco1: polymerase Sp6[@bib1]N/ApBS-*sox32* (cb527): probe synthesis *sox32*: linearize Not1: polymerase T7<https://zfin.org/ZDB-PUB-010810-1>\
ZFIN online publicationN/ApCS2+*ndr1*: mRNA synthesis *ndr1*: linearize Not1: polymerase Sp6[@bib17]N/ApCS2-*dusp4*: mRNA synthesis *dusp4*: linearize Not1: polymerase Sp6This studyN/ApCS2-*dusp4*\_ATG-mut: mRNA synthesis mutant *dusp4*: linearize Not1: polymerase Sp6This studyN/ApCS2-*fgf8a:* mRNA synthesis *fgf8a*: linearize Not1: polymerase Sp6[@bib58]N/A**Software and Algorithms**FIJI (ImageJ)[@bib49]<https://imagej.net/Fiji/Downloads>JASPAR[@bib33]<http://jaspar.genereg.net/>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Caroline Hill (<caroline.hill@crick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Zebrafish Husbandry {#sec4.3.1}

Wild type zebrafish (*Danio rerio*) were maintained under standard conditions ([@bib62]). Adult zebrafish were kept on a regular light-dark cycle (14 hours on/10 hours off) at 27°C. Note, analysis of early embryos precludes determination of animal sex.

All the zebrafish work was carried out under a UK Home Office License under the Animals (Scientific Procedures) Act 1986. The license underwent full ethical review and approval by the Francis Crick Institute's Animal Ethics Committee.

Method Details {#sec4.4}
--------------

### Zebrafish Embryo Culture {#sec4.4.1}

All experiments in live embryos were performed at 28°C. Embryos were carefully staged according to morphological features and where needed for time courses, collected in a 5 min interval after removing dividers from breeding tanks to ensure synchronization ([@bib28]). Embryos were fixed in 4% paraformaldehyde overnight at 4°C, dechorionated, dehydrated to 100% methanol and stored at -20°C until processing.

### Chemical Inhibitions {#sec4.4.2}

The inhibitors SU-5402 (Calbiochem, \#572631), PD-0325901 (Merck, \#444968) and SB-505124 (Sigma, \#S4696) were dissolved in DMSO and directly diluted in embryo medium at 10 μM, 5 μM and 50 μM respectively.

### Plasmids and mRNA Synthesis {#sec4.4.3}

The zebrafish *dusp4* open reading frame (ORF) was cloned by PCR amplification using pooled blastula stage cDNA with oligonucleotides elongated with BamH1/Xho1 sites that were used to clone the fragment into the pCS2+ plasmid. A version of pCS2+-*dusp4* was also generated for rescue of the translation blocking MO (MO1) in which five silent point mutations were introduced in the first 25 base pairs of the *dusp4* ORF, using the Agilent QuikChange XL kit according to the manufacturer's instructions. Primer sequences are given in [Table S1](#mmc2){ref-type="supplementary-material"}. For full length capped mRNA, the pCS2+-*ndr1*, pCS2-*Fgf8a* and pCS2+-*dusp4* plasmids were linearized using Not1 (NEB) and transcribed using SP6 RNA polymerase (NEB) for 2--3 hrs. Template DNA was removed using DNAseI (Worthington) treatment for 30 min at 37°C and mRNA was subsequently purified by Lithium Chloride extraction, reconstituted in water and stored at -80°C until injection ([@bib20], [@bib58]).

### Morpholino Injection {#sec4.4.4}

For a full list of MOs (Genetools), references, their use and dilutions, see [Table S1](#mmc2){ref-type="supplementary-material"}. MOs were diluted in H~2~O and injected in 1--2 cell stage embryos in a volume of 2 nl. The efficacy of each MO was determined by injecting a range of concentrations and effective concentrations ranged from 3--8 ng per embryo. For *dusp4*, a start site MO (MO1) was designed and two splice site MOs (MO2 and MO3) were used that have previously been characterized ([@bib8]). For both MO2 and MO3, knockdown was determined by RT-PCR in multiple experiments. For the MO rescue experiments, full length capped wild type *dusp4* mRNA was co-injected with the MO2 and MO3 at 400 pg per embryo. For rescue of MO1, the mutated version of *dusp4* mRNA was used (see above). The *dusp6* MO1 has been characterized previously ([@bib57]) and efficacy of the splice site *dusp6* MO (MO2) was determined by RT-PCR.

### WISH and Immunohistochemistry {#sec4.4.5}

All plasmids for the generation of riboprobes, with references can be found in the [Key Resources Table](#sec4.1){ref-type="sec"}. For probes that were generated from PCR products, see [Table S1](#mmc2){ref-type="supplementary-material"}. Standard WISH, including the addition of 5% dextran sulphate to the hybridization buffer, was performed as described ([@bib58]). In brief, samples were rehydrated to PBS/0.1% Tween (PTW) before hybridization with digoxigenin (Dig)-11-UTP- (Roche, \#11209256910) labeled riboprobes against the indicated target genes, overnight at 65°C. Embryos were then incubated overnight at 4°C with anti-Dig-AP (Roche, \#11093274910; 1:5000). Embryos were washed extensively in PTW before detecting alkaline phosphatase with NBT/BCIP (Sigma, \# B5655).

For FISH, samples were first incubated in 2% H~2~O~2~ in 100% methanol for 20 min to reduce background staining before rehydration to PTW. Hybridization with an additional riboprobe labeled with dinitrophenol (DNP)-11-UTP (Perkin Elmer, \#NEL555001EA) allowed two targets to be visualized simultaneously. Embryos were then incubated overnight at 4°C with anti-Dig-AP as for standard WISH, or anti-Dig-HRP (Roche, \#1207733910, 1:500), anti-DNP-HRP (Perkin Elmer, \#FP1129) or anti-DNP-AP (Vector labs MB-3100, 1:1000) antibodies, followed by extensive washes in PTW. To detect HRP, embryos were incubated with tyramide (Sigma, \#T2879) coupled to either fluorescein-NHS ester (Thermo Scientific, \#46410) or Cy5 mono NHS ester (Sigma, \#PA15101) for 25 min in the dark in PTW. Following the addition of 0.001% H~2~O~2~ signal was allowed to develop for 30 min. After two washes with PTW, Fast Red (Sigma, \#F4648) was used according to the manufacturer's instructions to detect the AP. The embryos were then extensively washed in PTW, and DAPI was used at 1:5000 as a nuclear counter stain.

For all FISH and regular WISH experiments, the number of representative embryos out of the total number of embryos stained, is depicted in the right bottom corner of each image. Sectioning of standard WISH-stained embryos was performed as previously described ([@bib58]). Embryos were embedded in paraffin, sectioned at 8 μm and counterstained with Nuclear Fast Red for 5 min (Vector laboratories, H3403).

Immunohistochemistry was performed as described ([@bib58]). Embryos were rehydrated, washed extensively in PBS/1% Triton X-100 and incubated in cold acetone at -20°C for 20 min, before blocking in 10% FBS and 1% Triton X-100 in PBS. Embryos were incubated with antibodies against P-Smad2 (Cell Signaling Technology, \#8828, 1:1000) and P-Erk (Sigma, \#M8159, 1:500) at 4°C overnight. For visualization, the following secondary antibodies were used at 1:500: donkey anti-rabbit Alexa Fluor 488, donkey anti-mouse Alexa Fluor 594, donkey anti-mouse Alexa Fluor 546, goat anti-rabbit Alexa Fluor 647 (Thermofisher), and DAPI as a nuclear counter stain.

### Generation of Ndr1-Expressing Clones {#sec4.4.6}

To generate clones of Ndr1-expressing cells, one- to two-cell stage embryos were either untreated or were injected with *dusp4* mRNA and raised until the 64- to 128-cell stage. At these stages, a single blastomere was injected with 1% dextran- fluorescein to allow Ndr1-expressing cells to be visualized and 10 pg capped *ndr1* mRNA under a stereomicroscope. The injected embryos were allowed to recover in E3 medium in agarose-coated dishes and either left untreated or treated with DMSO or 5 μM PD-0325901 from sphere stage, and then collected at germ ring stage for immunohistochemistry or FISH. Experiments were performed at least in duplicate and a minimum of four embryos was analyzed for each condition.

### Image Acquisition {#sec4.4.7}

All imaging for FISH-stained embryos and immuno-stained embryos was performed using Zeiss LSM710, 780 or 880 confocal microscopes. To this end, embryos were either mounted in 0.8% low melt agarose on 35 mm glass bottom dishes (Matek, P35G-1.5-14C) to image the lateral margin, or the entire margin was imaged by dissecting the yolk from the embryo which was then flat-mounted in Mowiol (Calbiochem, \#475904). Whole-mounted embryos were imaged with a 25×/0.8 LD LCI Plan-Apochromat water immersion lens, and flat-mounted embryos were imaged with a 10×/0.45 Ph1 Plan-Apochromat lens. For illustrative purposes, maximum or average intensity Z-projections from confocal stacks were generated and adjusted to enhance contrast and brightness where appropriate. Further adjustments were performed using Gaussian blur with a radius of one pixel and within experiments, adjustments were kept equal between control and treated samples. For Z-reconstructions specimens were mounted in 90% glycerol in 0.1 M Tris HCl pH 8.5 and imaged with a 25×/0.8 LD LCI Plan-Apochromat oil immersion lens. Light sheet imaging was performed using a Luxendo MuVi-SPIM, with resulting image stacks resliced to give the appropriate orientation.

### Dissociated Zebrafish Embryo Experiments {#sec4.4.8}

Zebrafish embryonic cell culture experiments were performed at 28°C with pre-warmed buffers ([@bib58]). Blastomeres were obtained from up to 1000 high--oblong stage embryos that were dechorionated in 2 mg/ml Pronase (Roche, \#10165921001) in E3 medium, washed extensively in E3 to remove remaining Pronase and equilibrated in Calcium free Ringers buffer, before gently dissociating cells using a P200 pipette in a volume of 10 ml. The cells were collected by centrifugation for 5 min at 1000 x g and the pellet was gently disrupted before resuspension in Leibovitz's L15 medium (Gibco, \#11415-064) without serum, at a density of 50 embryos/ml and seeded on 24 well tissue culture plates coated with poly-L lysine in a final volume of 1 ml. Human recombinant NODAL (R&D, \#3218-ND/CF) was dissolved in 4 mM HCl at 100 mg/ml, aliquoted in non-stick tubes, stored at -80°C and used at indicated concentrations without freeze-thawing. Human basic FGF (Peprotech, \#AF100-18b) was dissolved according to the manufacturer's instructions and dilutions of both recombinant proteins were made directly in serum free L15 medium in non-stick tubes. Seeded cells were incubated with the indicated concentrations of ligands for 2 hrs after which the medium was aspirated and the cells snap-frozen at -80°C until processing for qPCR. As controls, Western blotting was performed for P-Smad2 and P-Erk in parallel.

### qPCR {#sec4.4.9}

For qPCR on whole embryos, 5--10 embryos were snap frozen in a minimal amount of medium without dechorionation. qPCR was performed as previously described ([@bib58]) and for primer sequences see [Table S1](#mmc2){ref-type="supplementary-material"}. In brief, mRNA was extracted using Trizol (Thermo Fisher Scientific) and cDNA synthesis was performed on 500 ng mRNA using Affinityscript (Qiagen), both according to the manufacturer's instructions. qPCRs were performed using Fast SYBR Green Master mix (Thermo Fisher Scientific) on an ABI 7500 Fast (Applied Biosystems) thermocycler. For each primer set, qPCR efficiencies and specificity were first determined using standard curves of diluted cDNAs and melting curve analysis. Technical replicates for each condition were taken and experiments were repeated five times. Caculations were performed using the ΔΔCt method. Means ± SEM from at least two independent experiments are shown. Statistics were performed on these data using a t test.

### Western Blotting {#sec4.4.10}

Western blotting was performed as previously described ([@bib58]). Five to ten embryos were snap frozen and stored at -80°C until processing. Lysates were generated by homogenizing the pooled embryos in lysis buffer (10 μl per embryo; 20 mM Tris HCl pH 8, 2 mM EDTA pH 8, 0.5% NP-40, 25 mM β-glycerophosphate, 100 mM NaF, 20 nM Calyculin A, 100 mM sodium pyrophosphate and protease inhibitors). The equivalent of 1--2 embryos was loaded onto standard 15% SDS polyacrylamide gels. After electrophoresis, proteins were transferred to PDVF membrane (Millipore) and immunoblotted using standard techniques. The following antibodies were used: anti-phosphorylated-Erk (Sigma, \#M8159), anti-Erk (Santa Cruz, \#sc-94) and anti-Actin (Sigma, \#A3853).

### Smad2 Chromatin Immunoprecipitation (ChIP) {#sec4.4.11}

Chromatin immunoprecipitation (ChIP) assays were performed using 50% epiboly embryos treated from sphere stage with DMSO and SB-505124. Chromatin was prepared and sheared to a range of 0.3 to 0.7 kb by sonication and the equivalent of 70 μg of chromatin was used in each ChIP experiment and immunoprecipitated with a mix of rabbit anti-Smad2 (Thermo Fisher, \#700048) and rabbit anti-Smad2 (Cell Signaling technologies, \#5339) antibodies ([@bib11], [@bib39]). Individual input dilutions corresponding to treatments were used as qPCR standard curves to quantitate Smad2 binding in the corresponding region and these values were then normalized using the *actin* negative control region. As a positive control, we used a known Smad2-binding enhancer associated with *mixl1* ([@bib39]) and normalization was validated with the *sox10* TSS as a negative control region. For all oligonucleotides used in these experiments, see [Table S1](#mmc2){ref-type="supplementary-material"}.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Measuring Expression Profiles {#sec4.5.1}

Quantification of nuclear P-Smad2 and P-Erk intensity, relative to the margin on whole-mounted embryos was carried out as previously described ([@bib58]), but with modifications to allow semi-automation. Using ImageJ software ([@bib49]) individual nuclei were segmented from the DAPI staining of each optical slice by an automated threshold followed by binary water shedding. To avoid selecting mitotic figures, overlapping nuclei or small nuclear extremities, nuclei with a cross sectional area greater than 50 pixels (8.6 μm^2^) and circularity greater than 0.75 were selected. A region of interest (ROI) was drawn on each optical section to exclude nuclei from the enveloping layer (EVL) and YSL. Selected nuclei were used as ROIs to measure average DAPI intensity, as well as P-Smad2 and P-Erk intensity, and allowing P-Smad2 or P-Erk to DAPI ratios to be calculated. This was carried out on at least three optical sections per embryo. To measure the distance of each nucleus to the margin boundary, points along this boundary were marked out on a maximum projection of each embryo and a spline curve fitted using ImageJ software ([@bib49]), with the distance to the boundary taken as the minimum distance from each nuclear centroid to the boundary curve. For each time point the data were divided into 15 μm bins and within each bin weighted means of the normalized intensities across at least three embryos were calculated, as was the normalized standard deviation (as indicated in Figure legends).

To quantify intensity profiles around the margin for flat-mounted embryos stained by immunohistochemistry or FISH (for P-Smad2, P-Erk, *noto, ta, dusp4* and *lft2)*, the border between the YSL and embryonic margin was marked out on maximum projections and a spline curve fitted. At pixel intervals a line perpendicular to this boundary was calculated, and the intensity profile along this line 150 μm (approximately 10 cell tiers) into the embryo was measured. From this, an average profile around the margin was calculated by taking the mean intensities at pixel increments away from the boundary. The represented data show means of traces from at least three different embryos per condition, and their SD (as indicated in Figure legends).

### Quantification of Endodermal Cell Numbers {#sec4.5.2}

To determine endodermal cell numbers at 75% epiboly, embryos were stained by standard WISH for *sox17*, dehydrated in methanol and cleared in 80% glycerol. To visualize and count endodermal progenitors, the yolk was removed and the blastoderm flat-mounted on histological slides, imaged under a stereo microscope (Leica MZ8) after which endodermal progenitors were counted manually. Care was taken to exclude dorsal forerunner cells. For quantifications of endodermal cell numbers at 50% epiboly, embryos were stained for *lft2* and *sox32*, flat-mounted and imaged under a confocal microscope (as described above) to generate Z-stacks with an interval of 2--3 μm. *sox32*-positive endodermal cells were counted manually only recording cells positive cells for both *sox32* and *lft2* to exclude dorsal forerunner cells and *sox32* staining in the YSL. In initial experiments, these counts were done blind. For all experiments where cell numbers were counted, data are represented as an open red circle. Statistics were performed on these data using a Mann-Whitney U test (as indicated in Figure legends). For quantifications of endodermal cell numbers surrounding the Ndr1-expressing clones, *sox32*-positive cells were counted manually using the Z-Stacks. The surface area of *lft2* expression domains was measured using Image J software over at least 11 embryos from three independent experiments. Statistics were performed on these data using a two-tailed t test.

### Identification of *dusp4* Regulatory Regions {#sec4.5.3}

To confirm that *dusp4* is a direct Nodal target, genomic regulatory regions associated with *dusp4* that bound Smad2 were identified. To this end, three published datasets were used ([@bib15], [@bib31], [@bib39]), and two of these datasets identified *dusp4* as a direct Nodal target gene. To identify all regions with potential Smad binding sites, enhancers marked by H3K4me1 and H3K27Ac at dome-stage ([@bib7]) were located and scanned for a FoxH1--Smad2--Smad4 motif using JASPAR ([@bib33]). Using these criteria, two potential enhancer regions were identified, located at -31.3kb and -3.2kb from the *dusp4* TSS.
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